• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声心动图引导下心内膜射频消融治疗梗阻性肥厚型心肌病的初步经验。

Septal Ablation with Radiofrequency Catheters Guided by Echocardiography for Treatment of Patients with Obstructive Hypertrophic Cardiomyopathy: Initial Experience.

机构信息

Instituto Dante Pazzanese de Cardiologia,São Paulo, SP - Brasil.

出版信息

Arq Bras Cardiol. 2022 May;118(5):861-872. doi: 10.36660/abc.20200732.

DOI:10.36660/abc.20200732
PMID:35137775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9368870/
Abstract

BACKGROUND

Hypertrophic cardiomyopathy (HCM) can cause obstruction in the left ventricular outflow tract (LVOT), and be responsible for the onset of limiting symptoms, such as tiredness. When such symptoms are refractory to pharmacological treatment, interventionist alternative therapies can be useful, such as septal ablation through the infusion of alcohol in the coronary artery or through myectomy. Recently, the use of a radiofrequency (RF) catheter for endocardial septal ablation guided by electroanatomic mapping has proven to be efficient, despite the high incidence of complete atrioventricular block. An alternative would be the application of RF at the beginning point of the septal gradient guided by the transesophageal echocardiography (TEE). The echocardiography is an imaging method with high accuracy to determine septal anatomy.

OBJECTIVE

To assess the long term effect of septal ablation for the relief of ventricular-arterial gradient, using TEE to help place the catheter in the area of larger septal obstruction. Besides, to assess the effects of ablation on the functional class and echocardiographic parameters.

METHODS

Twelve asymptomatic patients, with LVOT obstruction, refractory to pharmacological therapy, underwent endocardial septal ablation with 8mm-tip catheters, whose placement was oriented in the region of larger obstruction, assisted by the TEE. Temperature-controlled and staggered RF applications were performed. After each application, the gradient was reassessed and a new application was performed according to the clinical criterion. The effects of RF applications were assessed both for the gradient at rest and for that provoked by the Valsalva maneuver, and considering the gradient. The differences were significant when p-value was lower than or equal to 0.05.

RESULTS

It was possible to observe that the mean reduction of the maximum gradients was from 96.8±34.7 mmHg to 62.7±25.4 mmHg three months after the procedure (p=0.0036). After one year, the mean of maximum gradient was 36.1±23.8 mmHg (p=0.0001). The procedure was well tolerated, without records of complete atrioventricular block nor severe complications.

CONCLUSION

The TEE-guided septal ablation was efficient and safe, and the results were maintained during the clinical follow-up period. It is a reasonable option for the interventionist treatment of LVOT obstruction in HCM.

摘要

背景

肥厚型心肌病(HCM)可导致左心室流出道(LVOT)阻塞,并引发疲劳等限制症状。当这些症状对药物治疗无反应时,介入性替代疗法可能会有所帮助,例如通过冠状动脉内输注酒精或通过心肌切除术进行间隔消融。最近,使用射频(RF)导管在电解剖标测引导下进行心内膜间隔消融已被证明是有效的,尽管完全性房室传导阻滞的发生率较高。另一种方法是在经食管超声心动图(TEE)引导下,在间隔梯度的起始点应用 RF。超声心动图是一种具有高准确性的成像方法,可用于确定间隔解剖结构。

目的

评估 TEE 辅助下心内膜间隔消融治疗缓解心室-动脉梯度的长期效果,在 TEE 引导下帮助将导管放置在间隔较大阻塞部位。此外,评估消融对功能分级和超声心动图参数的影响。

方法

12 名无症状患者,LVOT 阻塞,对药物治疗无反应,接受 8mm 尖端导管的心内膜间隔消融治疗,其放置方向为较大阻塞区域,由 TEE 辅助。进行温度控制和交错的 RF 应用。每次应用后,重新评估梯度,并根据临床标准进行新的应用。评估 RF 应用对静息时梯度和瓦尔萨尔瓦动作引起的梯度的影响,并考虑梯度。当 p 值低于或等于 0.05 时,差异具有统计学意义。

结果

可以观察到,在术后 3 个月时,最大梯度的平均降低幅度从 96.8±34.7mmHg 降至 62.7±25.4mmHg(p=0.0036)。术后 1 年,最大梯度平均值为 36.1±23.8mmHg(p=0.0001)。该手术耐受性良好,无完全性房室传导阻滞或严重并发症记录。

结论

TEE 引导下的间隔消融是有效且安全的,在临床随访期间结果得以维持。它是肥厚型心肌病 LVOT 阻塞介入治疗的合理选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/63ec65e2843f/0066-782X-abc-118-05-0861-gf06-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/29b48ba8307b/0066-782X-abc-118-05-0861-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/8e2c2b6df49f/0066-782X-abc-118-05-0861-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/58333cd91266/0066-782X-abc-118-05-0861-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/d44617cd5116/0066-782X-abc-118-05-0861-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/db6c219461af/0066-782X-abc-118-05-0861-gf05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/5cebd1cb5164/0066-782X-abc-118-05-0861-gf06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/0544636fa99c/0066-782X-abc-118-05-0861-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/d4903f8ffafc/0066-782X-abc-118-05-0861-gf02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/9b89d214d051/0066-782X-abc-118-05-0861-gf03-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/d4f1da9b55d0/0066-782X-abc-118-05-0861-gf04-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/cb51bf3e00d1/0066-782X-abc-118-05-0861-gf05-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/63ec65e2843f/0066-782X-abc-118-05-0861-gf06-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/29b48ba8307b/0066-782X-abc-118-05-0861-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/8e2c2b6df49f/0066-782X-abc-118-05-0861-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/58333cd91266/0066-782X-abc-118-05-0861-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/d44617cd5116/0066-782X-abc-118-05-0861-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/db6c219461af/0066-782X-abc-118-05-0861-gf05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/5cebd1cb5164/0066-782X-abc-118-05-0861-gf06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/0544636fa99c/0066-782X-abc-118-05-0861-gf01-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/d4903f8ffafc/0066-782X-abc-118-05-0861-gf02-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/9b89d214d051/0066-782X-abc-118-05-0861-gf03-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/d4f1da9b55d0/0066-782X-abc-118-05-0861-gf04-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/cb51bf3e00d1/0066-782X-abc-118-05-0861-gf05-en.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d39/9368870/63ec65e2843f/0066-782X-abc-118-05-0861-gf06-en.jpg

相似文献

1
Septal Ablation with Radiofrequency Catheters Guided by Echocardiography for Treatment of Patients with Obstructive Hypertrophic Cardiomyopathy: Initial Experience.超声心动图引导下心内膜射频消融治疗梗阻性肥厚型心肌病的初步经验。
Arq Bras Cardiol. 2022 May;118(5):861-872. doi: 10.36660/abc.20200732.
2
Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation.经导管射频消融室间隔治疗肥厚型梗阻性心肌病的流出道压差:一种使用CARTOSound®技术指导消融的新方法。
Europace. 2016 Jan;18(1):113-20. doi: 10.1093/europace/euv302. Epub 2015 Nov 4.
3
Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy?使用射频能量消融肥厚的室间隔:肥厚型梗阻性心肌病患者降低压差的一种替代方法?
J Invasive Cardiol. 2013 Jun;25(6):E128-32.
4
A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.一种用于肥厚性梗阻性心肌病中射频导管消融间隔肥厚的新方法。
Indian Heart J. 2016 Sep-Oct;68(5):618-623. doi: 10.1016/j.ihj.2016.02.007. Epub 2016 Apr 14.
5
Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.梗阻性肥厚型心肌病间隔心肌切除术的长期疗效
J Cardiol. 2015 Jul;66(1):57-62. doi: 10.1016/j.jjcc.2014.08.010. Epub 2014 Sep 18.
6
Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.Valsalva动作与运动在肥厚型心肌病左心室流出道梗阻超声心动图评估中的比较
Eur J Echocardiogr. 2010 Oct;11(9):763-9. doi: 10.1093/ejechocard/jeq063. Epub 2010 May 15.
7
[Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].经胸超声心动图引导下经皮心肌间隔射频消融术治疗梗阻性肥厚型心肌病患者的疗效与安全性
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Apr 24;47(4):284-290. doi: 10.3760/cma.j.issn.0253-3758.2019.04.005.
8
Radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a case report.梗阻性肥厚型心肌病的射频消融治疗:一例报告
Eur Heart J Case Rep. 2024 Jul 23;8(8):ytae359. doi: 10.1093/ehjcr/ytae359. eCollection 2024 Aug.
9
A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China.中国经主动脉延伸室间隔心肌切除术治疗梗阻性肥厚型心肌病的回顾性临床研究。
Eur J Cardiothorac Surg. 2013 Mar;43(3):534-40. doi: 10.1093/ejcts/ezs332. Epub 2012 Jul 3.
10
Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.梗阻性肥厚型心肌病酒精间隔消融术后的短期和长期预后:一家参考中心的经验
Rev Port Cardiol (Engl Ed). 2019 Jul;38(7):473-480. doi: 10.1016/j.repc.2019.08.003. Epub 2019 Sep 5.

引用本文的文献

1
Percutaneous endocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy.肥厚性梗阻性心肌病患者的经皮心内膜间隔射频消融术
BMC Cardiovasc Disord. 2025 Aug 2;25(1):564. doi: 10.1186/s12872-025-05002-1.
2
Septal Preparation for TAVR Using Radiofrequency Catheters in Patients With LVOT Obstruction: 1-Year Follow-Up.使用射频导管对左心室流出道梗阻患者进行经导管主动脉瓣置换术的间隔准备:1年随访
JACC Case Rep. 2025 Jun 11;30(14):103606. doi: 10.1016/j.jaccas.2025.103606.
3
Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: a meta-analysis.

本文引用的文献

1
Focused Endocardial Septal Ablation: A New Technique to Treat Postmyectomy Recurrent Gradient.聚焦心内膜室间隔消融术:一种治疗心肌梗死后再发梯度的新技术。
Ann Thorac Surg. 2021 Oct;112(4):e279-e281. doi: 10.1016/j.athoracsur.2021.01.029. Epub 2021 Jan 30.
2
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 年美国心脏病学会/美国心脏协会肥厚型心肌病诊断和治疗指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20.
3
射频消融治疗肥厚型梗阻性心肌病的疗效与安全性:一项荟萃分析。
Future Cardiol. 2025 Jun;21(8):611-619. doi: 10.1080/14796678.2025.2509368. Epub 2025 May 22.
4
Efficacy and safety of myectomy and radiofrequency septal ablation for treating hypertrophic obstructive cardiomyopathy.心肌切除术和射频消融术治疗肥厚性梗阻性心肌病的疗效与安全性。
Open Heart. 2025 Apr 4;12(1):e003166. doi: 10.1136/openhrt-2025-003166.
5
Radiofrequency Ablation for Patients with Hypertrophic Obstructive Cardiomyopathy Accompanied by Severe Left Ventricular Outflow Tract Obstruction.射频消融治疗肥厚型梗阻性心肌病伴严重左心室流出道梗阻患者
Anatol J Cardiol. 2024 Nov 25;28(12):599-605. doi: 10.14744/AnatolJCardiol.2024.4486.
6
Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024.肥厚型心肌病诊断与治疗指南 - 2024
Arq Bras Cardiol. 2024 Jul 26;121(7):e202400415. doi: 10.36660/abc.20240415.
7
Percutaneous endocardial septal radiofrequency ablation on syncope in patients with hypertrophic obstructive cardiomyopathy: a short-term safety and efficacy study.经皮心内膜间隔射频消融治疗肥厚型梗阻性心肌病患者晕厥的短期安全性和疗效研究
Ann Med Surg (Lond). 2024 Jun 4;86(7):3880-3886. doi: 10.1097/MS9.0000000000002243. eCollection 2024 Jul.
8
A Narrative Review of Emerging Therapies for Hypertrophic Obstructive Cardiomyopathy.肥厚型梗阻性心肌病新兴治疗方法的叙述性综述。
Curr Cardiol Rev. 2023;19(4):e240323214927. doi: 10.2174/1573403X19666230324102828.
9
Septal Ablation with Radiofrequency and the Use of New Technologies in Patients with Hypertrophic Cardiomyopathy in an Electrophysiology LaboratoryReply.肥厚型心肌病患者在电生理实验室进行射频间隔消融及新技术应用的回复。
Arq Bras Cardiol. 2022 Oct 21;119(4):635-637. doi: 10.36660/abc.20220143.
10
Effect of Perioperative Comprehensive Nursing Intervention on the Rehabilitation Effect of Radiofrequency Ablation for Patients with Hypertrophic Obstructive Cardiomyopathy.围手术期综合护理干预对肥厚型梗阻性心肌病患者射频消融康复效果的影响。
Contrast Media Mol Imaging. 2022 Aug 11;2022:6436073. doi: 10.1155/2022/6436073. eCollection 2022.
Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.
经皮心肌内室间隔射频消融治疗肥厚型梗阻性心肌病。
J Am Coll Cardiol. 2018 Oct 16;72(16):1898-1909. doi: 10.1016/j.jacc.2018.07.080.
4
Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography.成人经胸超声心动图全面检查操作指南:美国超声心动图学会的建议
J Am Soc Echocardiogr. 2019 Jan;32(1):1-64. doi: 10.1016/j.echo.2018.06.004. Epub 2018 Oct 1.
5
Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach.肥厚性梗阻性心肌病的间隔消融术:经冠状动脉和心内膜途径
Am J Med Sci. 2016 Nov;352(5):466-471. doi: 10.1016/j.amjms.2016.08.025. Epub 2016 Sep 21.
6
A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.一种用于肥厚性梗阻性心肌病中射频导管消融间隔肥厚的新方法。
Indian Heart J. 2016 Sep-Oct;68(5):618-623. doi: 10.1016/j.ihj.2016.02.007. Epub 2016 Apr 14.
7
Endocardial radiofrequency septal ablation - A new option for non-surgical septal reduction in patients with hypertrophic obstructive cardiomyopathy (HOCM)?: A systematic review of clinical studies.心内膜射频间隔消融术——肥厚型梗阻性心肌病(HOCM)患者非手术性间隔减容的新选择?:临床研究的系统评价
Int J Cardiol. 2016 Nov 1;222:772-774. doi: 10.1016/j.ijcard.2016.08.123. Epub 2016 Aug 6.
8
Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy.射频间隔心肌成形术治疗肥厚梗阻型心肌病所致的有症状患者。
Heart Rhythm. 2016 Sep;13(9):1885-90. doi: 10.1016/j.hrthm.2016.04.018. Epub 2016 Apr 27.
9
Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation.经导管射频消融室间隔治疗肥厚型梗阻性心肌病的流出道压差:一种使用CARTOSound®技术指导消融的新方法。
Europace. 2016 Jan;18(1):113-20. doi: 10.1093/europace/euv302. Epub 2015 Nov 4.
10
Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014.外科室间隔心肌切除术与酒精室间隔消融术:评估2014年的争议状况
Circulation. 2014 Oct 28;130(18):1617-24. doi: 10.1161/CIRCULATIONAHA.114.011580.